[ABCL] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
21-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -212.28%
YoY- -149.86%
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 9,179 21,545 139,331 207,908 3,202 30.09%
PBT -48,602 -31,412 84,710 155,915 -1,641 133.14%
Tax -1,452 -1,519 24,762 39 82 -
NP -47,150 -29,893 59,948 117,000 -1,641 131.38%
Tax Rate - - -29.23% -0.02% - -
Total Cost 56,329 51,438 79,383 90,909 4,843 84.59%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin -513.67 -138.75 43.03 56.27 -51.24 77.86%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS -0.16 -0.10 0.21 0.43 -0.01 99.90%
EPS Diluted -0.16 -0.10 0.21 0.37 -0.01 99.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.